MYD88 and cancer: The binding of TLR2 to the adapter protein MyD88 recruits TRAF6 which consequently promotes the activation of the NF-κB Thus, the activation of this pathway may enhance carcinogenesis and development of lung cancer in addition to regulating cancer proliferation.